Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

por Wu, Y. Linda, van Hyfte, Grace, Özbek, Umut, Reincke, Marlene, Gampa, Anuhya, Mohamed, Yehia I., Nishida, Naoshi, Wietharn, Brooke, Amara, Suneetha, Lee, Pei-Chang, Scheiner, Bernhard, Balcar, Lorenz, Pinter, Matthias, Vogel, Arndt, Weinmann, Arndt, Saeed, Anwaar, Pillai, Anjana, Rimassa, Lorenza, Naqash, Abdul Rafeh, Muzaffar, Mahvish, Huang, Yi-Hsiang, Kaseb, Ahmed O., Kudo, Masatoshi, Pinato, David J., Ang, Celina
Publicado 2023

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

por Vithayathil, Mathew, D’Alessio, Antonio, Fulgenzi, Claudia Angela Maria, Nishida, Naoshi, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Saeed, Anwaar, Wietharn, Brooke, Hildebrand, Hannah, Wu, Linda, Ang, Celina, Marron, Thomas U., Weinmann, Arndt, Galle, Peter R., Bettinger, Dominik, Bengsch, Bertram, Vogel, Arndt, Balcar, Lorenz, Scheiner, Bernhard, Lee, Pei-Chang, Huang, Yi-Hsiang, Amara, Suneetha, Muzaffar, Mahvish, Naqash, Abdul Rafeh, Cammarota, Antonella, Zanuso, Valentina, Pressiani, Tiziana, Pinter, Matthias, Cortellini, Alessio, Kudo, Masatoshi, Rimassa, Lorenza, Pinato, David J., Sharma, Rohini
Publicado 2023

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

por Wu, Yue Linda, Fulgenzi, Claudia Angela Maria, D’Alessio, Antonio, Cheon, Jaekyung, Nishida, Naoshi, Saeed, Anwaar, Wietharn, Brooke, Cammarota, Antonella, Pressiani, Tiziana, Personeni, Nicola, Pinter, Matthias, Scheiner, Bernhard, Balcar, Lorenz, Huang, Yi-Hsiang, Phen, Samuel, Naqash, Abdul Rafeh, Vivaldi, Caterina, Salani, Francesca, Masi, Gianluca, Bettinger, Dominik, Vogel, Arndt, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Galle, Peter R., Kudo, Masatoshi, Rimassa, Lorenza, Singal, Amit G., Sharma, Rohini, Cortellini, Alessio, Gaillard, Vincent E., Chon, Hong Jae, Pinato, David J., Ang, Celina
Publicado 2022

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

por D’Alessio, Antonio, Fulgenzi, Claudia Angela Maria, Nishida, Naoshi, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Gaillard, Vincent E., Saeed, Anwaar, Wietharn, Brooke, Hildebrand, Hannah, Wu, Linda, Ang, Celina, Marron, Thomas U., Weinmann, Arndt, Galle, Peter R., Bettinger, Dominik, Bengsch, Bertram, Vogel, Arndt, Balcar, Lorenz, Scheiner, Bernhard, Lee, Pei‐Chang, Huang, Yi‐Hsiang, Amara, Suneetha, Muzaffar, Mahvish, Naqash, Abdul Rafeh, Cammarota, Antonella, Personeni, Nicola, Pressiani, Tiziana, Sharma, Rohini, Pinter, Matthias, Cortellini, Alessio, Kudo, Masatoshi, Rimassa, Lorenza, Pinato, David J.
Publicado 2022

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

por Vithayathil, Mathew, D'Alessio, Antonio, Fulgenzi, Claudia A. M., Nishida, Naoshi, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Saeed, Anwaar, Wietharn, Brooke, Hildebrand, Hannah, Wu, Linda, Ang, Celina, Marron, Thomas U., Weinmann, Arndt, Galle, Peter R., Bettinger, Dominik, Bengsch, Bertram, Vogel, Arndt, Balcar, Lorenz, Scheiner, Bernhard, Lee, Pei‐Chang, Huang, Yi‐Hsiang, Amara, Suneetha, Muzaffar, Mahvish, Naqash, Abdul Rafeh, Cammarota, Antonella, Personeni, Nicola, Pressiani, Tiziana, Pinter, Matthias, Cortellini, Alessio, Kudo, Masatoshi, Rimassa, Lorenza, Pinato, David J., Sharma, Rohini
Publicado 2022